BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21184732)

  • 1. WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.
    Zeilstra J; Joosten SP; Wensveen FM; Dessing MC; Schütze DM; Eldering E; Spaargaren M; Pals ST
    Biochem Biophys Res Commun; 2011 Mar; 406(1):1-6. PubMed ID: 21184732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium.
    Kim BM; Mao J; Taketo MM; Shivdasani RA
    Gastroenterology; 2007 Aug; 133(2):529-38. PubMed ID: 17681174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intestinal Wnt/TCF Signature.
    Van der Flier LG; Sabates-Bellver J; Oving I; Haegebarth A; De Palo M; Anti M; Van Gijn ME; Suijkerbuijk S; Van de Wetering M; Marra G; Clevers H
    Gastroenterology; 2007 Feb; 132(2):628-32. PubMed ID: 17320548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
    Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial.
    Campbell KL; McTiernan A; Li SS; Sorensen BE; Yasui Y; Lampe JW; King IB; Ulrich CM; Rudolph RE; Irwin ML; Surawicz C; Ayub K; Potter JD; Lampe PD
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1767-74. PubMed ID: 17855695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.
    Fevr T; Robine S; Louvard D; Huelsken J
    Mol Cell Biol; 2007 Nov; 27(21):7551-9. PubMed ID: 17785439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer.
    Boon EM; van der Neut R; van de Wetering M; Clevers H; Pals ST
    Cancer Res; 2002 Sep; 62(18):5126-8. PubMed ID: 12234972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
    D'Orazio D; Muller PY; Heinimann K; Albrecht C; Bendik I; Herzog U; Tondelli P; Bauerfeind P; Müller H; Dobbie Z
    Anticancer Res; 2002; 22(6A):3409-14. PubMed ID: 12530096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the IFITM family as a new molecular marker in human colorectal tumors.
    Andreu P; Colnot S; Godard C; Laurent-Puig P; Lamarque D; Kahn A; Perret C; Romagnolo B
    Cancer Res; 2006 Feb; 66(4):1949-55. PubMed ID: 16488993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.